Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carole Longson

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Lancet (London, England)|March 2, 2017
Antimicrobial resistance: a light at the end of the tunnel?Colm T Leonard, Derek Ward, Carole Longson
The Lancet. Oncology|April 15, 2008
Rituximab for follicular non-Hodgkin lymphomaElangovan Gajraj, Helen Chung, Carole Longson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2011
The National Institute for Health and Clinical Excellence and its role in assessing the value of new cancer treatments in England and WalesRebecca Trowman, Helen Chung, Carole Longson, et al.
The Lancet. Oncology|July 9, 2009
Lenalidomide for the treatment of relapsed multiple myelomaElangovan Gajraj, Helen Chung, Meindert Boysen, et al.
The Lancet. Oncology|April 4, 2009
10 years of NICE: still growing and still controversialPeter Littlejohns, Sarah Garner, Nick Doyle, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
Understanding the Role and Evidence Expectations of Health Technology Assessment and Coverage/Payer Bodies: What Are They Looking for, and How and Why Does This Differ From What Regulators Require?Chris Henshall, Lloyd Sansom, Hans-Georg Eichler, et al.
European Heart Journal|February 16, 2006
Improving patient access to novel medical technologies in EuropePeter Kearney, Graham Stokoe, Günter Breithardt, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Lancet (London, England)|March 2, 2017
Antimicrobial resistance: a light at the end of the tunnel?Colm T Leonard, Derek Ward, Carole Longson
The Lancet. Oncology|April 15, 2008
Rituximab for follicular non-Hodgkin lymphomaElangovan Gajraj, Helen Chung, Carole Longson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2011
The National Institute for Health and Clinical Excellence and its role in assessing the value of new cancer treatments in England and WalesRebecca Trowman, Helen Chung, Carole Longson, et al.
The Lancet. Oncology|July 9, 2009
Lenalidomide for the treatment of relapsed multiple myelomaElangovan Gajraj, Helen Chung, Meindert Boysen, et al.
The Lancet. Oncology|April 4, 2009
10 years of NICE: still growing and still controversialPeter Littlejohns, Sarah Garner, Nick Doyle, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
Understanding the Role and Evidence Expectations of Health Technology Assessment and Coverage/Payer Bodies: What Are They Looking for, and How and Why Does This Differ From What Regulators Require?Chris Henshall, Lloyd Sansom, Hans-Georg Eichler, et al.
European Heart Journal|February 16, 2006
Improving patient access to novel medical technologies in EuropePeter Kearney, Graham Stokoe, Günter Breithardt, et al.
Pageof 2